Search for a trial

A phase IIIB, multicentre, multinational, randomized, open-label trial to compare the efficacy and safety of ovarian stimulation with GONAL-f day 1 to day 5 followed by Pergoveris starting day 6 to Pergoveris starting day 1 in women between 36 and 40 years of age undergoing assisted reproductive technique (ART)

The overall objective of this trial is to generate data on the ovarian stimulation profile obtained when Pergoveris® is started either on stimulation day 1 or stimulation day 6 in ART patients between 36 and 40 years of age (both inclusive). A…

Ovarian hyperstimulation in women with estrogen-receptor positive breastcancer who opt for embryo- or oocyte freezing: Is the Tamoxifen dosage sufficient to protect women against estrogen exposure? (TAMOXI project: a pilot study).

The objective of this pilot-study is to investigate if the current dosage of tamoxifen supplied to women with estrogen receptor positive breastcancer who opt for embryo- or oocyte freezing is protective during the whole period of hormone stimulation…

The protective effect of tamoxifen in women with ER-positive breast cancer who opt for cryopreservation of oocytes or embryos: a prospectively controlled study.

The objective of this study is to investigate the relation between tamoxifen use during COS, endoxifen levels reached during COS, and recurrence-free survival (locoregional recurrence, distant recurrence or death from any cause) when compared with…

Mental wellbeing and quality of life after insertion of a LNG-IUD or Cu-IUD. A randomized patient preference trial.

To compare the effects of LNG-IUD (Mirena® of Kyleena®) versus Cu-IUD (T-Safe® or Multi-Safe®) on mental well-being and quality of life.